We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

High Density Microarrays Profile Noncoding RNAs

By LabMedica International staff writers
Posted on 18 Nov 2008
The first high-density microarray has been launched for the profiling of noncoding ribonucleic acids (RNAs).

The NCode human and mouse noncoding RNA microarrays consist of both noncoding RNA and messenger RNA (mRNA) content on the same array. The arrays are designed by Invitrogen Corp. (Carlsbad, CA, USA) and then manufactured by Agilent Technologies, Inc. (Santa Clara, CA, USA), using the company's proprietary SurePrint technology. Invitrogen will market and distribute the product.

Transcription, or the synthesis of RNA as directed by DNA, involves not only messenger RNA (mRNA) corresponding to the genes that are translated into proteins, but also tens of thousands of long non-protein-coding RNAs. The noncoding RNAs appear to comprise a vast hidden layer of genetic programming implicated in development and disease pathways in mammals.

"Noncoding RNA transcripts play a variety of roles in a cell, ranging from simple housekeeping to complex regulatory functions, and evidence is mounting that their expression is perturbed in many cancers,” said John Mattick, Ph.D., professor of molecular biology at the University of Queensland (Australia)

"When we talked to scientists about their interest in studying noncoding RNA, many told us they wanted a microarray that consisted of both mRNA and noncoding RNA content, which would help them elucidate the function of specific noncoding RNAs in relation to known pathways of gene expression,” said Amy Butler, vice president of Gene Expression Profiling for Invitrogen. "We answered with an array-based solution, exclusive to Invitrogen that has tens of thousands of coding and noncoding sequences which could answer multiple scientific questions with a single experiment.”

Invitrogen provides products and services that support academic and government institutions, and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition.

Agilent Technologies is a measurement company and a technology leader in communications, electronics, life sciences, and chemical analysis.

Related Links:
Invitrogen
Agilent Technologies
University of Queensland




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel

Latest Molecular Diagnostics News

Genetic-Based Tool Predicts Survival Outcomes of Pancreatic Cancer Patients
18 Nov 2008  |   Molecular Diagnostics

Urine Test Diagnoses Early-Stage Prostate Cancer
18 Nov 2008  |   Molecular Diagnostics

New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
18 Nov 2008  |   Molecular Diagnostics